Beclomethasone dipropionate in pediatric perennial extrinsic rhinitis.
Neuman I, Toshner D·Annals of allergy
A double-blind, crossover trial of beclomethasone dipropionate intranasal aerosol was undertaken in 30 children suffering from long-term perennial extrinsic rhinitis refractive to conventional therapy with a success rate of 83%. There were no side effects. Maximum improvement was a seen a week after initiation of the a…